Bruker (BRKR) Short-term Investments (2014 - 2026)

Bruker (BRKR) has reported Short-term Investments for 12 consecutive years, with $32.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments fell 1.52% year-over-year to $32.3 million; the trailing twelve-month figure through Jun 2026 stood at $32.3 million (down 1.52% YoY), and the FY2025 full-year result was $23.8 million, down 8.81% from the prior year.
• Short-term Investments grew to $32.3 million in Q2 2026 per BRKR's latest filing, from $28.2 million in the prior quarter.
• Across five years, Short-term Investments topped out at $100.0 million in Q1 2022 and bottomed at $30.5 in Q3 2023.
• Historically, Short-term Investments has averaged $31.9 million across 5 years, with a median of $28.8 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments slumped 81.0% in 2022, then soared 112458916.39% in 2024.
• Over 5 years, Short-term Investments stood at $19.0 million in 2022, then surged by 51.58% to $28.8 million in 2023, then declined by 9.38% to $26.1 million in 2024, then slipped by 8.81% to $23.8 million in 2025, then soared by 35.71% to $32.3 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $32.3 million, $28.2 million, and $23.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.